In this review, we discuss the imaging features of diseases and conditions ranging from neoplastic to nonoperative post-treatment effects to unique conditions of the spine. Additionally, advanced imaging may increase diagnostic certainty in cases where conventional imaging characteristics of benign lesions and malignant pathology are variable. www.neurosurgery-online.com I n this review, we describe the imaging characteristics of a variety of neoplastic and non-neoplastic spine conditions, discuss the nonsurgical post-treatment appearance of the spinal column, and present examples of advanced imaging techniques. We will predominantly focus on magnetic resonance imaging (MRI); however, examples of imaging features on other modalities will be included as appropriate.
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n this review, we describe the imaging characteristics of a variety of neoplastic and non-neoplastic spine conditions, discuss the nonsurgical post-treatment appearance of the spinal column, and present examples of advanced imaging techniques. We will predominantly focus on magnetic resonance imaging (MRI); however, examples of imaging features on other modalities will be included as appropriate.
Although not exhaustive, the range of cases presented is intended to highlight key and unique imaging features that may be encountered in practice by neurosurgeons and radiologists alike. We also restrict this review to diseases involving adults. Where appropriate, advanced imaging techniques (mainly MRI) that may have clinical application will be discussed. Degenerative, traumatic, and infectious spine diseases are beyond the scope of this article and presented in another review.
ABBREVIATIONS: ADC, apparent diffusion coefficient; CISS, constructive interference in steady state; CNS, central nervous system; CSF, cerebrospinal fluid; CT, computed tomography; DSC, dynamic contrast-enhanced; DTI, diffusion tensor imaging; DWI, diffusion weighted imaging; FDG-PET, [ 18 F]fluoro-2-deoxy-d-glucose positron emission tomography; FIESTA, fast imaging employing steady-state acquisition; Gy, Gray; MRI, magnetic resonance imaging; RF, radiofrequency; SRS, stereotactic radiosurgery; STIR, short tau inversion recovery; T1-W, T1-weighted; VCF, vertebral compression fracture
IMAGING OF SPINAL NEOPLASMS Vertebral Marrow Imaging
Before highlighting the imaging of spinal neoplasms, a discussion of vertebral marrow imaging is warranted. The spectrum of vertebral bone marrow abnormalities ranges from benign (eg, hyperplastic red marrow) to malignant (eg, myeloma, metastasis). Imaging findings can be diffuse (eg, hyperplastic red marrow or hematological disorders) or localized (eg, metastasis, plasmacytoma, hemangioma). Moreover, agerelated and benign reactive marrow changes can complicate the interpretation of spinal MRI.
On MRI, T1-weighted (T1-W), T2-W fatsaturated (or short tau inversion recovery, STIR), and postcontrast T1-W fat-saturated sequences are required for spinal marrow and neoplasm evaluation. 1 Computed tomography (CT) of the spine is useful for characterizing bony architecture, cortical bone, and evaluation of the instrumented spine. Dual energy spine CT can decrease the streak artifact from spinal hardware and can facilitate spinal canal evaluation. 2 CT myelography is useful to opacify the thecal sac to look for structural causes of cord and/or cauda equina compression or mass effect. 3 However, newer metal artifact reduction MRI techniques are decreasing the need for CT myelography if patients can get MRI. 2 
"Benign" Vertebral Bone Marrow Changes
Normally, bone marrow is diffusely red (hematopoietic) from childhood through young adulthood. T1-W MRI is the sequence of choice to evaluate vertebral bone marrow-related changes. 1 Red marrow is usually darker than subcutaneous fat, but mildly hyperintense to normal intervertebral disc ( Figure 1A ). After age 40, vertebral bone marrow will convert from red to yellow (fatty; Figure 1B-1D ). 4 Three patterns are usually observed: (1) fatty replacement in a band-like configuration along the endplates, (2) larger confluent (globular) areas of marrow replacement, and (3) small focal areas of marrow replacement. 5 Vertebral bone marrow is highly reactive to stressors and changes in its composition can be seen on imaging. Known environmental factors that cause red marrow hyperplasia include anemia, changes in diet, chemotherapy (Figure 2 ), chronic hypoxia, and treatment with granulocyte colony stimulating factor. 6 Chronic mechanical hemolysis due to long distance running, 7 folate deficiency during pregnancy, 8 and chronic anemia due to sickle cell disease 4 can also cause red marrow hyperplasia.
FIGURE 1. Normal bone marrow. T1-W sagittal MRI images of age-related changes of red marrow converting to yellow marrow. A, Twenty-five-year-old female with homogenous red marrow that is isointense to normal muscle. B, Forty-one-year-old female with early foci of yellow marrow conversion (yellow arrow). C, Sixty-year-old male with predominantly yellow marrow and interspersed islands of red marrow (yellow arrow). D, Eighty-four-year-old male shows varying levels of predominantly yellow marrow, especially affecting the sacrum (yellow arrow).

FIGURE 2. Hyperplastic red marrow. Eighty-one-year-old female with non-Hodgkin
Hemangioma
Vertebral body hemangiomas are common benign lesions found incidentally on CT and MRI examinations of the spine. The imaging appearance reflects the underlying histologic features, specifically the volume of fat, vessels, and soft tissue. The typical imaging appearance on CT is that of coarsened vertical trabeculae, with paucity of horizontal trabeculae, creating a pattern described as "corduroy" or "polka dot" on axial images. The cortex is nonexpanded and intact. On MR, these lesions are T1-hyperintense, reflecting their high volume of fat, hypointense on STIR or T2 fat-saturated images, and nonenhancing.
Hemangiomas with a greater vascular component and lower volume of fat can have an atypical appearance. The CT appearance may not be substantially different than typical hemangiomas. On MR, these are iso-to hypointense on T1-W images, T2 and STIR hyperintense, and may enhance. This appearance can lead to a diagnostic dilemma as it similar to primary bone tumors and metastases. Aggressive hemangiomas are rare lesions that are seen to actively enlarge in a short period of time, have an associated soft tissue mass, and may invade the epidural space and potentially cause cord or nerve root compression. Others may cause pain without obvious compression of neural structures. Approximately 1% of hemangiomas fall into this symptomatic category. 
Malignant Vertebral Body and Epidural Disease
Malignant involvement of the vertebral column can be diffuse, focal, or a mixture of both patterns. Hematological disorders tend to diffusely involve the spine and are less likely to have cortical destruction. 9 Metastases are focal or multifocal. Myeloma, lymphoma, and leukemia tend to diffusely infiltrate the spinal column. Myeloid leukemias, however, can form nodular or mass-like concretions called focal granulomas, or granulocytic sarcomas. These chloromas can occur before leukemia ensues and are occasionally multifocal. 10 Bone infarcts are a specific condition associated with acute lymphoblastic leukemia and usually present with back pain (Figure 3 ).
11
On CT, the marrow has a permeative appearance in diffuse myeloma, leukemia, and lymphoma. Both focal and diffuse marrow disease are associated with vertebral compression fractures (VCF). Infrequently, complete collapse of the vertebral body, or vertebral plana, occurs in leukemia, and more rarely in myeloma and lymphoma. 12 Chloromas are focally lytic with prominent extraosseous components (Figure 4) . Lymphoma, which is usually metastatic, can appear as an "ivory" vertebral body on radiographs or CT, indicating diffuse vertebral body sclerosis by near-complete tumor infiltration. 13 Please note that the differential diagnosis of an ivory vertebra does include leukemia, myeloma, osteomyelitis, vertebral hemangioma, and metastatic disease. Of note, CT can detect lytic myeloma lesions if radiographs are normal. 14 MRI best evaluates the extent of osseous and any extraosseous disease ( Figure 5 ). The anterior vertebral body is involved in 80% of cases, and the pedicles in 60%. 15 On MRI, the lesions are 
FIGURE 10. Malignant vertebral compression fracture. Eighty-one-year-old female with acute back pain and myelopathic symptoms. Sagittal T1-W A, postcontrast T1-W fat-saturated B, and T2-W fat-saturated C images show a T8 VCF with T1-W dark signal, postcontrast enhancement, and T2-W high signal (yellow arrows). There is also bowing of the posterior wall of the vertebral body and epidural extension of tumor (curved white arrows); all findings characteristic of malignant VCF.
and lymphoma can have overlapping MRI appearance; however, lymphoma can also have circumferential paravertebral extension with preservation of the cortex, called a "wrap-around sign" ( Figure 6 ). 17 Metastatic lesions of the spine tend to be focal and can be osteoblastic, osteolytic, or mixed type, and can readily have epidural and paravertebral extension. 16, 18 Osteoblastic primary malignancies include carcinoid, medulloblastoma, nasopharyngeal carcinoma, prostate, and urothelial cancers. 18 Due to the sclerotic nature of the tumors, the lesions are usually hyperdense on CT and diffusely T1-W and T2-W hypointense on MRI. Breast, cervix, lung, and ovarian cancers tend to be mixed blastic and lytic ( Figure 7 ).
18 T1-W and T2-W signal, and postcontrast enhancement is variable depending on the primary type and level of sclerosis. In both cases, contrast enhancement is variable depending upon the degree of sclerosis; sclerosis and enhancement are inversely related.
Osteolytic metastases occur in 5% to 10% of all cancer patients, with 5% of these patients having spinal cord compression. The most common primary cancers causing lytic lesions are breast (lytic type), lung, melanoma, renal, and thyroid types ( Figure 8) . 18 On CT, single or multifocal lytic lesions with permeative margins are typical. Bone scintigraphy has very low sensitivity for purely osteolytic lesions. [ 18 F]fluoro-2-deoxy-d-
FIGURE 11. Schwannoma. Sixty-five-year-old woman with neck pain. Axial T1-W postcontrast fat-saturated A and axial T2-W B images show a homogeneously enhancing mass that is extradural, dumbbell-shaped, and widens the neural foramen (yellow arrows).
glucose positron emission tomography (FDG-PET) with CT coregistration is 98% sensitive for detection of spinal metastasis. 19 For lung cancer and lymphoma, [ 18 F]-FDG PET is reportedly more sensitive and useful for detection of early osseous disease before cortical destruction ensues. 20, 21 Additionally, [ 18 F]-FDG PET is more sensitive for detection of osteolytic metastasis than of osteoblastic metastasis. 20, 21 Any patient with acute myelopathy in the setting of a known primary malignancy should get MRI, if there are no contraindica- tions (eg, pacemaker dependence, spinal cord stimulator). If the patient cannot get emergent MRI, emergent CT myelography for spinal cord compression should be considered after consultation with the radiologist on duty.
Benign vs Pathological VCF
The differentiation of benign (osteoporotic) from pathological (malignant) VCF is a conundrum frequently faced in clinical practice. Although both types of fractures can show dark T1-W and bright T2-W signal and show variable degrees of postcontrast enhancement, 16 some additional features can help tell them apart. Signal changes in benign fractures commonly reflect a combination of edema and hemorrhage, and they have a band-like appearance immediately under the fracture of the end plate (T2 cleft sign; Figure 9 ). 15 Apart from areas of edema, remaining bone marrow in the fractured vertebral body appears normal, due to a preserved matrix. The posterior elements are rarely edematous with a benign fracture. 15, 16 Malignant fractures do not show a T2 cleft sign due to underlying destruction of the bony trabeculae (matrix), often associated
FIGURE 13. Psammomatous meningioma. Seventy-five-year-old woman with back pain. A, Sagittal postcontrast T1-W image demonstrates a homogeneously enhancing mass occupying the spinal canal (yellow arrow). B, Sagittal T2-W image shows the mass compressing the spinal cord and expanding the subarachnoid space (dashed white arrow), indicating an extramedullary, intradural location. The mass is T2-W dark (B, yellow arrow) due to dense calcification, typical of psammomatous meningioma.
with edema throughout the affected vertebral body. 15, 16 Other features include involvement of the posterior elements (especially pedicles), 15, 22 bowing of the posterior wall of the vertebral body, 23 extraosseous paraspinal and epidural disease extension, and presence of metastatic disease at other spinal levels 15 ( Figure 10 ).
Extramedullary Tumors
The most common tumor of the intradural, extramedullary space is the schwannoma. 24 It originates from Schwann cells, usually arising from the dorsal roots of the spinal cord. Due to their eccentric position in the spinal canal, the tumor tends to push the cord, conus medullaris, or filum terminale to the contralateral side. 16 Schwannomas also follow the nerve root through the neural foramina, widening it over time. This bidirectional growth both into and out of the spinal canal gives a "dumbbell" appearance to the tumor ( Figure 11 ). Schwannomas demonstrate this appearance due to a core of predominantly cellular Antoni A cells surrounded by a rim of hypocellular Antoni B cells. Neurofibromas have a similar appearance reflecting the fibrocollagenous tissue at the core surrounded by myxomatous tissue. Peripheral nerve sheath tumors demonstrate central T2-hypointensity surrounded by T2-hyperintensity creating a "target sign." 25 On T2-W imaging, the target sign shows heterogeneously high signal, but not as high as cerebrospinal fluid (CSF; Figure 12 ). 26 Of note, neurofibromas can look like schwannomas on MRI, likely due to their mixed Schwann cell and fibroblast histology. 26 However, neurofibromas of the spine are rare, except in patients with neurofibromatosis type 1. 27 Meningiomas are the second most common intraspinal tumor ( Figure 13 ). Usually, they occur in the thoracic spine, followed by the cervical and lumbar spine. 26 They are often solitary; however, they can be multiple in patients with neurofibromatosis type 2. Over 95% of spinal meningiomas are benign and designated WHO grade 1 and females are affected 4 times more than males. 16 On MRI, meningiomas are iso-to hypointense to spinal cord on both T1-W and T2-W sequences. They homogenously enhance after contrast administration and variably show a dural tail sign, indicating the site of their origin. 26 The dural tail sign, however, is not specific to meningiomas. Lastly, leptomeningeal carcinomatosis is a condition that should be considered if patients have a primary malignancy. These malignancies can be outside the central nervous system (CNS; eg, lung, breast cancer) or from the CNS (eg, glioblastoma, medulloblastoma). 16, 28 Three enhancement patterns have been described on MRI: (1) smooth, diffuse enhancement of the leptomeninges ("sugar-coating"; Figure 14 ), (2) multiple nodular lesions studding the leptomeninges, and (3) a dominant leptomeningeal mass growing from drop metastasis in the thecal sac termination. 16 
Miscellaneous Tumors of the Spinal Column
A small family of lesions falls into this category of unique tumors that do not fit into the "metastasis" category but can range from benign to malignant. We will focus on osteoid osteoma and chordoma. Ten per cent of all osteoid osteomas occur in the spine and comprise fibrovascular growths surrounded by bony sclerosis. They have a predilection for the posterior elements, especially the pedicles. 16 CT usually shows a central lucent/hypodense region with a surrounding rim of sclerosis ( Figure 15 ). On MRI, the lesion is associated with surrounding vasogenic edema, although the central nidus is usually less visible than on CT. 29 These benign lesions can be quite large, and if over 1.5 cm, are referred to as osteoblastomas. 29 Chordoma is a malignant tumor of notochord remnants that can occur in the clivus, sacrum, or the spine itself (especially the lumbar spine). Chordomas have the ability to extend from one vertebral body across the endplate to the next vertebral body, a feature not seen with other spine tumors. 16 These destructive, midline lesions show calcifications in 90% of cases on CT ( Figure 16A ). On MRI, they are intensely T2-W bright with internal septae, heterogenous signal on T1-W images, and show diffuse enhancement on postcontrast T1-W images ( Figure 16B-16D ).
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Spinal Cord Tumors
Intramedullary tumors generally expand the cord and show varying degrees of edema and enhancement. The most common intramedullary tumors include astrocytoma and ependymoma. Less common are hemangioblastoma and cord metastases.
Spinal ependymomas are the most common intramedullary tumor and usually occur in the mid-adult years. 28 The tumors have sharp borders and compress, rather than infiltrate, adjacent normal cord. The most common type is the classic type (WHO grade 2); however, anaplastic (WHO grade 3) and myxopapillary (WHO grade 1) types exist. 16 The latter type is typically seen at the conus medullaris termination in adults. Ependymomas usually occur sporadically, but can be seen with syndromes like neurofibromatosis type 2. 31 Usually occurring in the cervical spine, ependymomas are sharp margined, homogenously enhancing, slightly T2-W bright tumors. They tend to hemorrhage and 20% to 33% demonstrate peripheral T2-W hypointensity resulting from hemosiderin and ferritin deposition, often called the "cap sign" (Figure 17) . [31] [32] [33] Intramedullary cysts are commonly associated with this tumor (>90%). 34 Spinal astrocytomas are the second most common intramedullary tumor in adults. 31 Due to their infiltrative nature, spinal astrocytomas are associated with a poor prognosis compared to ependymoma. Usually starting in the cervical cord, the tumor grows by local extension, with variable degrees of leptomeningeal seeding. 16 The tumor can extend multiple spinal levels or involve the whole spinal cord. On MRI, lower grade tumors can show hyperintense T2-W signal without enhancement (Figure 18 ). Higher
FIGURE 15. Osteoid osteoma. Fifty-nine-year-old female with back pain. Parasagittal A and axial B CT images of the lumbar spine show a well corticated lesion of the left pedicle of tL1 (yellow arrows). The lesion is centrally hyperdense surrounded by a lytic rim.
FIGURE 16. Sacral chordoma. Forty-two-year-old male with lower back pain and pelvic fullness. A, Sagittal noncontrast CT image of the sacrum shows a large mass arising from the distal sacrum (yellow arrow), with internal coarse calcification (white arrow). B, Sagittal T1-W MR image shows the mass is isointense to muscle, with robust enhancement on postcontrast fat-saturated sagittal T1-W image C. The mass has hyperintense T2-W signal on sagittal fat-saturated T2-W imaging. Note the internal area of dark signal (D, black arrow), corresponding to the calcifications on the CT (A, white arrow). These calcifications reflect intrinsic cartilaginous matrix in chordoma.
grade tumors can present as a long segment enhancing intramedullary mass, with longer segments of edema (high T2-W signal) extending cranial and caudal to the enhancing region ( Figure 19) . 31 Intramedullary cysts are less common compared to ependymomas.
Hemangioblastoma is the third most common primary spinal cord neoplasm, representing 5% to 10% of spinal cord tumors. 31 The tumor can be either sporadic or associated with Von HippelLindau syndrome. In either case, the tumor appears distinct from the other 2 primary tumors discussed above; the tumor is usually
FIGURE 17. Spinal ependymoma. Fifty-five-year-old male with progressive myelopathy. Sagittal A and axial B T2-W images show an expansile intramedullary mass within the cervical spine. There is a dominant cystic component (yellow arrows). Long segment T2-W hypointense signal is present, representing intralesional hemorrhage (A, solid white arrow). Cord edema extends cephalad from the mass (A, dashed white arrow). Axial postcontrast fat-saturated T1-W image C shows minimal peripheral enhancement (curved white arrow).
an enhancing nodule with significant arteriovenous shunting. Due to the shunting, venous hypertension results and is thought to be the cause of the extensive edema associates with hemangioblastomas ( Figure 20) . 16 Large tumoral cysts and syrinx are also seen in imaging. MRI is the modality of choice; however, direct catheter angiography may be needed to identify the arterial feeders and draining veins prior to surgical intervention.
Cord metastatic disease is relatively rare considering the prevalence of metastasis in the rest of the body. 35 Its incidence, however, is rising, likely due to cancer patients living longer and greater use of MRI to evaluate for indolent disease. Usually patients have rapid progression of myelopathy and paralysis, with poor prognosis. Nonspecific MRI findings are the hallmark of cord metastatic disease. Lesions can be singular or multifocal, yet each is small (Figure 21 ). Cord edema is typically out of proportion to the size of the lesion(s). Intramedullary cysts are not seen with cord metastases and hemorrhage can rarely occur, signified by high T1-W signal and low T2-W signal.
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ADVANCED IMAGING OF SPINAL ONCOLOGIC DISEASE
Conventional MRI of the spine for evaluation of oncologic disease has been limited due to its dependence on 2-dimensional, anatomic sequences. Recently, advanced techniques such as MR diffusion and perfusion have been investigated with promising results.
Diffusion Imaging of the Spine
Diffusion weighted imaging (DWI) and diffusion tensor imaging (DTI) are MRI techniques based on measuring the microscopic diffusion of water in living tissues. DWI is the original method that looks at changes in water diffusion using a scalar metric called the apparent diffusion coefficient (ADC). As water diffusion decreases (ie, diffusion restriction), ADC values decrease and a given lesion or process will decrease in signal (darken), compared to adjacent unaffected tissue. 37 Although DWI is mainly employed to evaluate intracranial pathology (eg, stroke, pyogenic abscess, hypercellular intracranial tumor), some utility in spine imaging has been demonstrated. Spinal cord DWI is useful in characterizing intramedullary tumors. 38 DWI can help characterize lesions with high nuclearto-cytoplasm ratio cells (hypercellular) and those that have hemorrhage, both of whom would show dark signal on ADC maps and high signal on trace DWI images. DWI improves evaluation of bone marrow lesions. Diseases with underlying bone marrow changes, such as myeloma, are notoriously difficult to interpret using conventional MRI. DWI can increase the conspicuity of underlying marrow lesions and help differentiate them from hyperplastic or other benign changes of the marrow (Figure 22 ).
DTI is a second evolution of diffusion imaging and examines the level of water diffusion restriction while incorporating a directional component. It has been used to evaluate normal and abnormal brain white matter tracts, which usually have a highly bundled architecture, thereby restricting water diffusion along the long axis of the tract, rather than across the tract. This property called anisotropy can be both quantified and used to generate images showing white matter tracts (diffusion tensor tractography).
An example of utility in spinal imaging is shown in the differentiation of ependymoma from astrocytoma (Figure 23 ),
FIGURE 18. Low-grade astrocytoma (glioma). Twenty-two-year-old man with back pain. Sagittal A and axial B T2-W images show an ill-defined hyperintense expansile intramedullary mass (yellow arrow) in the thoracic spinal cord. Postcontrast sagittal C and axial D images show no associated enhancement.
which can be difficult on conventional spine MRI. Experimental studies have shown that DTI can help distinguish these tumors: ependymoma tends to displace intact white matter tracts, as it is not an infiltrating tumor, while astrocytoma infiltrates and destroys white matter tracts. 38 Validation and standardization of this technique is pending, thereby hindering its wide spread use.
Perfusion Imaging of the Spine
Recent work on marrow and cord MR perfusion imaging has shown utility in spine oncologic imaging. Specifically, dynamic contrast-enhanced (DSC) MR perfusion imaging is a technique that relies on intravenous gadolinium-based contrast administration and can model the kinetic properties of the contrast as it moves through tissue. Recent work by Kadem et al 39 has 
FIGURE 19. High-grade astrocytoma (glioma). A, Young man with progressive myelopathy and back pain. Sagittal T1-W postcontrast image reveals an expansile intramedullary mass with large areas of heterogeneous enhancement (yellow arrows). B, The sagittal T2-W image shows heterogeneous T2-W signal within the tumor (solid white arrow) and long segment edema extending into the thoracic cord (dashed white arrows
FIGURE 20. Hemangioblastoma. Thirty-year-old woman with neck pain. A, The sagittal T1-W image shows a well-defined expansile, intramedullary mass (yellow arrow). B, The postcontrast fat-saturated T1-W image shows a small enhancing subpial nodule on the dorsal surface (white arrow). C, The sagittal T2-W image demonstrates the cystic nature of the mass (yellow arrow) and cord edema (curved white arrow) cephalad to the lesion.
shown the utility of this technique in differentiating hyper-vs hypovascular metastatic vertebral body lesions. DSC perfusion imaging is also being investigated to assess lesion vascularity changes after radiosurgery ( Figure 24) . A recent study evaluating DSC perfusion found that peak tissue perfusion showed higher sensitivity and specificity than DWI and conventional MRI to diagnose primary intramedullary tumors compared to tumor-like conditions (eg, demyelination). 40 The lack of clinical efficacy and effectiveness trials has limited adoption of this technique; this, however, may change once enough evidence is discovered.
NONSURGICAL POST-TREATMENT IMAGING
Radiation-Related VCF
There is a 10% to 40% risk of VCF after single fraction radiosurgery resulting from radiation effects on compromised vertebral marrow. 41 Factors that put the patient at highest risk for VCF include lytic metastasis, location in the thoracolumbar or lumbar segments, age greater than 55 yr, pre-existing fracture or fracture deformity, and pain. 42 For this reason, cement augmentation is occasionally performed before radiation or chemotherapy in highrisk patients.
Cement Augmentation and Ablation
Pain produced by osseous spinal metastases is challenging to treat. Patients are often debilitated and at greater risk for surgical morbidity. High surgical complication rates with resultant decreased quality of life are especially undesirable in patients with a limited life expectancy. For this reason, minimally invasive procedures are popular options for this population. Vertebroplasty and kyphoplasty are now among the most commonly used treatments in spinal oncology for pain related to mechanical instability. 43 In patients with spinal metastases, pathological fractures can occur under normal physiological stress. Cement augmentation provides a high rate of pain relief and improved quality of life. 41 Percutaneous ablative therapy is another treatment used for the pain of osseous metastases, and in some cases to provide local tumor control. 44 Energy-based ablation destroys tumor through either thermal (heat or cold) or nonthermal mechanisms. Radiofrequency (RF) ablation uses thermal energy to produce coagulation necrosis of the tumor as well as destruction of pain sensitive nerve fibers. Microwave ablation is a subtype of RF ablation, though with distinct device and applicator differences. Microwave ablation zones are larger, hotter, and produced faster compared with RF current. 45 Cryoablation destroys tissue by application of freezing temperature. This technique involves coaxial placement of a probe with pressurized circulating argon that rapidly cools producing a temperature drop to approximately 100
• C within seconds. Cryoablation is predominantly used for tumors with an extraosseous soft-tissue component because the ablated volume is visible on CT images. Ablation is often followed by cement augmentation to prevent potential instability. 42 Imaging after ablation is performed approximately 2 mo after treatment to allow for a decrease in procedure-related inflammation ( Figure 25 ). The ablation cavity is composed of central coagulation necrosis surrounded by a rim of hemorrhagic congestion and granulation tissue. T1-W bright signal and mild T2-W bight signal may be present within the cavity. Enhancement within the treatment field should be followed closely as it may reflect treatment failure. 46 Comparison with pre-ablation images is required to assess adequacy of treatment. Residual or recurrent tumor will be T2-W bright signal and enhancement at the margins of the ablation cavity. This occurs most commonly at the posterior vertebral body and pedicles: sites not amenable to aggressive ablation secondary to proximity to the spinal cord and nerve roots. Vascular fibrosis relating to treatment may have a similar appearance, complicating definitive diagnosis. Fibrosis should not be FDG avid; therefore, imaging with 18F-FDG PET/CT may be useful in difficult cases.
Radiation Myelopathy
Radiation myelopathy is a biologic response of the cord to radiation injury (Figure 26 ). Toxic doses of radiation disrupt the blood spinal cord barrier and promote vascular endothelial cell death resulting in demyelination and necrosis. A conventional fractionated radiotherapy total dose of 45 to 50 Gray (Gy) in 1.8-2 Gy daily fractions (or equivalent) has a very low risk of permanent myelopathy, estimated to range from 0.03% to 0.2%. 47 Stereotactic radiosurgery (SRS) uses a high dose per fraction with a steep gradient adjacent to the spinal cord. Dose tolerance in the setting of SRS has been found to differ significantly from limits extrapolated from conventional fractionation; limits are not yet well established. 48 
Radiation-Related Marrow Signal Changes
The acute and chronic MRI signal changes of marrow within the radiation field are well described. In the acute phase, increased signal on T2 and STIR images reflects marrow edema, cellular depletion, vascular congestion, and hemorrhage. In the chronic phase, the yellow marrow has characteristic high T1 signal ( Figure 26 ). Alternatively, a band of marginal intermediate T1 signal surrounding a central high T1 region is thought to represent red marrow surrounding a central fatty core. 49 The evolution of signal changes depends upon patient age and radiation dose.
SPINAL CORD HERNIATION VS SPINAL ARACHNOID CYST
The differentiation of spinal cord herniation from spinal arachnoid cyst can be difficult. The former condition is a rare one thought to occur due to a tear in the ventral dura of the thoracic spine. MRI is the study of choice, and sagittal T2-W imaging usually shows focal ventral buckling of the thoracic spinal cord. Axial imaging shows the ventral cord adherent to the dura, without intervening CSF (Figure 27 ). 50 Focal myelomalacia at the point of cord adhesion to the dura can be present.
The appearance of spinal cord herniation resembles that of a dorsal intradural arachnoid cyst. Some techniques are available to help differentiate the 2 conditions. High-resolution T2-W sequences can help visualize dorsal nerve roots traversing the subarachnoid space, a feature of spinal cord herniation. If the nerve roots are peripherally located at the level of the presumed "herniation," a dorsal arachnoid cyst may be suspected ( Figure 28 ). Additionally, phase-contrast MRI of the thoracic spine will show normal biphasic CSF flow in spinal cord herniation, whereas attenuated and turbulent flow will be seen with a dorsal arachnoid cyst. 51 Thoracic myelography followed by thoracic spine CT can be used; however, findings can be variable and the amount of radiation used is not trivial. Misdiagnosis of these 2 conditions is common (up to 45% in one analysis 52 ), so consultation with the neuroradiologist is essential and appropriate specialized MRI sequences (such as steady-state free precession, like constructive interference in steady state [CISS] , fast imaging employing steady-state acquisition [FIESTA] ) are used to differentiate spinal cord herniation from dorsal arachnoid cyst.
Tarlov Cysts
Extradural arachnoid cysts associated with nerve roots (Tarlov cysts) form when arachnoid membrane herniates through a dural defect associated with a spinal nerve. The wall is composed of vascularized connective tissue lined with arachnoid tissue, and the cysts often contain nerve root fibers and ganglion cells. 53 Tarlov cysts are typically asymptomatic unless mass effect is sufficient to impinge upon the involved nerve roots. Approximately 20% to 30% of patients with sacral Tarlov cysts visualized on MRI have clinical symptoms. 54 Myelography is performed to determine the degree of connectivity with the thecal sac. If no contrast is seen entering the Tarlov cyst on delayed imaging after a lumbar myelogram, the cyst is considered to have a "one-way valve" type connection, and is amenable to percutaneous drainage. After drainage, fibrin sealant may be injected as a long-term treatment to prevent reaccumulation of CSF ( Figure 29 ). 
CONCLUSION
We have discussed the imaging features of diseases and conditions ranging from neoplastic to nonoperative post-treatment effects to unique conditions of the spine. Conventional imaging characteristics of benign lesions and malignant pathology can be varied. In these cases, advanced imaging may increase diagnostic certainty. We encourage our neurosurgical colleagues to routinely consult the neuroradiologist for assistance in imaging these conditions.
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